SCHEMBL6991398

SCHEMBL6991398

N#CCN1CCC(=C2c3cc(F)ccc3CCn3ccnc32)CC1

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTAFR P25105 2/20 0.38
HRH1 P35367 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6989791 0.85 HRH1 (0.40) PTAFRHRH1
SCHEMBL5060492 0.83 HRH1 (0.47) PTAFRHRH1
SCHEMBL6987106 0.81 PTAFR (0.43) PTAFRHRH1
SCHEMBL5056412 0.74 HRH1 (0.47) PTAFRHRH1
Water SCHEMBL5056711 0.74 PTAFR (0.42) PTAFRHRH1
SCHEMBL27546512 0.73 PTAFR (0.43) PTAFRHRH1
SCHEMBL6995295 0.68 HRH1 (0.43) PTAFRHRH1
SCHEMBL6991281 0.68 HRH1 (0.43) PTAFRHRH1
Water SCHEMBL27458437 0.68 PTAFR (0.44) PTAFRHRH1
SCHEMBL6990285 0.68 ADRA1A (0.41) PTAFRHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0588858-B1 IMIDAZO 2,1-b] 3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE JANSSEN PHARMACEUTICA NV (BE) 2003-09-17 EP disclosed
US-5468743-A Imidazo[2,1-b]benzazepine derivatives, compositions and method of use JANSSEN PHARMACEUTICA N.V. (BE) 1995-11-21 US disclosed
EP-0588858-A1 IMIDAZO 2,1-b] 3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE JANSSEN PHARMACEUTICA N.V. (BE) 1994-03-30 EP disclosed
WO-1992022551-A1 IMIDAZO[2,1-b][3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE JANSSEN PHARMACEUTICA N.V. (BE) 1992-12-23 WO disclosed
EP-0518435-A1 Imidazo[2,1-b][3]benzazepine derivatives, compositions and method of use JANSSEN PHARMACEUTICA N.V. (BE) 1992-12-16 EP disclosed